Company intelligence
Cure First
Research Services
Seattle, US
11 employees
Founded 2012
4 public signals
About Cure First
Cure First is putting patients first by accelerating the identification of safer, more effective, and highly specific cancer treatments using functional genomics strategies that combine RNA interference, novel drugs, computational tools, and robotics in a collaborative, practical and multidisciplinary research effort .
Verified activity
Signals from Cure First
4 published signals
Research & Knowledge
Cure First's PARIS® Test is CLIA-certified and available for clinical use across the United States for patients with solid tumors, including children with brain tumors.
Reported by Cure First
Products & Services
Cure First offers the PARIS test, a functional precision medicine assay applicable across all solid tumors, in a CLIA certified laboratory.
Reported by Carla Grandori, MD. Ph.D.
Research & Knowledge
Cure First was named one of the top highlighted scientific opportunities by the National Cancer Institute's Annual Plan and Professional Judgment Budget for Advancing Functional Precision Medicine.
Reported by Carla Grandori, MD. Ph.D.
Research & Knowledge
Cure First is focused on extending the PARIS test approach to pediatric cancers, including children with brain tumors, where treatment options and data are still limited.
Reported by Carla Grandori, MD. Ph.D.